Cytosorbents Corporation
Cytosorbents Corporation scores highest on Earnings (46) and lowest on Price (0). Its PosiPenta is 25.02 out of 100, weaker than most similar companies.
On the Penta Grid this week, Cytosorbents Corporation is Grid #810 of 837 in the Healthcare sector in United States, and Grid #3,815 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Cytosorbents Corporation | 25.02 | 0 | 46 | 28 | 7 | 43 |
| Neuphoria Therapeutics Inc. | 37.69 | 43 | 30 | 17 | 62 | 37 |
| BeyondSpring Inc. | 35.27 | 0 | 38 | 11 | 92 | 36 |
| Modular Medical, Inc. | 34.94 | 28 | 42 | 19 | 39 | 45 |
| Marker Therapeutics, Inc. | 42.05 | 34 | 40 | 39 | 62 | 35 |
| Cocrystal Pharma, Inc. | 32.74 | 3 | 51 | 48 | 13 | 48 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.71 |
| P/B ratio | -17.25 |
EEarnings
| Trailing EPS | ₹-549.35 |
| Forward EPS | ₹0.00 |
NNitro
| Price | 389.28 |
| 52-week high | 1742.76 |
| 52-week low | 268.99 |
| Fall from 52-week high | 77.7% |
TTorque
| Return on equity (ROE) | -336.21% |
| Debt-to-equity | 4.93 |
AAnchor
| Beta (price swings) | 1.37 |
| Market cap | ₹122 Cr |
| Insider holding | 16.25% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Cytosorbents Corporation's PosiPenta score?
Cytosorbents Corporation's PosiPenta is 25.02 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Cytosorbents Corporation stand on the Penta Grid?
On the Penta Grid this week, Cytosorbents Corporation is Grid #810 of 837 in the Healthcare sector in United States, and Grid #3,815 of 4,000 in United States.
Which PosiPenta pillar is strongest for Cytosorbents Corporation?
Earnings (growth), with a score of 46 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Cytosorbents Corporation?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.